Demasking of epithelial cell adhesion molecule (EpCAM) on circulating epithelial tumor cells by Tween®20 treatment in breast cancer patients

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 4, 2012, Pages 701-708

  Hekimian, Katya ^a   Stein, Ernst Ludwig ^b   Pachmann, Ulrich ^b   Pachmann, Katharina ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF BAYREUTH   (Germany)

Author keywords

circulating epithelial tumor cells; demasking by Tween 20 treatment; EpCAM; laser scanning cytometry

Indexed keywords

DETERGENT; EPITHELIAL CELL ADHESION MOLECULE; EPITOPE; GLYCOPROTEIN; LIPOPROTEIN; MEMBRANE LIPID; MEMBRANE PROTEIN; ORGANIC SOLVENT; POLYSORBATE 20;

ANTIGEN BINDING; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER PATIENT; CELL VIABILITY; EPITHELIUM CELL; ERYTHROCYTE; HUMAN; HUMAN CELL; INCUBATION TEMPERATURE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR CELL;

ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CELL ADHESION MOLECULES; CELL COUNT; DETERGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; HUMANS; NEOPLASTIC CELLS, CIRCULATING; POLYSORBATES; TIME FACTORS;

EID: 84860489041     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.2011.812     Document Type: Article

References (36)

1. Klein CA. From single disseminated tumor cells to metastasis insights from molecular genetic analyses of single cells. Verh Dtsch Ges Pathol 2003;87:158-64.
2. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002;2:563-72. (Pubitemid 37328923)
3. Maheswaran S, Haber DA. Circulating tumor cells: a window into cancer biology and metastasis. Curr Opin Genet Dev 2010;20:96-9.
4. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889;133:571-3.
5. Balzar M, Winter MJ, de Boer CJ, Litvinov SV. The biology of the 17-1A antigen (Ep-CAM). J Mol Med 1999;77:699-712.
6. Pachmann K, Heiss P, Demel U, Tilz G. Detection and quantifi - cation of small numbers of circulating tumour cells in peripheral blood using laser scanning cytometer (LSC ® ). Clin Chem Lab Med 2001;39:811-7. (Pubitemid 32899131)
7. Pachmann K, Clement JH, Schneider CP, Willen B, Camara O, Pachmann U, et al. Standardized quantifi cation of circulating peripheral tumor cells from lung and breast cancer. Clin Chem Lab Med 2005;43:617-27. (Pubitemid 41460612)
8. Pachmann K, Dengler R, Lobodasch K, Fröhlich F, Kroll T, Rengsberger M, et al. An increase in cell number at completion of therapy may develop as an indicator of early relapse: quantifi cation of circulating epithelial tumor cells (CETC) for monitoring of adjuvant therapy in breast cancer. J Cancer Res Clin Oncol 2008;134:59-65. (Pubitemid 350060685)
9. Gastl G, Spizzo G, Obrist P, D ü nser M, Mikuz G. Ep-CAM overexpression in breast cancer as a predictor of survival. Lancet 2000;356:1981-2.
10. Spizzo G, Went P, Dirnhofer S, Obrist P, Simon R, Spichtin H, et al. High Ep-CAM expression is associated with poor prognosis in nodepositive breast cancer. Breast Cancer Res Treat 2004;86:207-13. (Pubitemid 39070963)
11. Balzar M, Briaire-de Bruijn IH, Rees-Bakker HA, Prins FA, Helfrich W, de Leij L, et al. Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions. Mol Cell Biol 2001;21:2570-80. (Pubitemid 32222108)
12. Schmoll HJ, Arnold D. When wishful thinking leads to a mistyeyed appraisal: the story of the adjuvant colon cancer trials with edrecolomab. J Clin Oncol 2009;27:1926-9.
13. Haas C, Krinner E, Brischwein K, Hoffmann P, Lutterb ü se R, Schlereth B, et al. Mode of cytotoxic action of T cell-engaging BiTE antibody MT110. Immunobiology 2009;214:441-53.
14. Ruf P, Gires O, J ä ger M, Fellinger K, Atz J, Lindhofer H. Characterisation of the new EpCAM-specifi c antibody HO-3: implications for trifunctional antibody immunotherapy of cancer. Br J Cancer 2007;97:315-21. (Pubitemid 47196752)
15. Winter MJ, Nagtegaal ID, van Krieken JH, Litvinov SV. The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. Am J Pathol 2003;163:2139-48. (Pubitemid 37466457)
16. Flieger D, Hoff AS, Sauerbruch T, Schmidt-Wolf IG. Infl uence of cytokines, monoclonal antibodies and chemotherapeutic drugs on epithelial cell adhesion molecule (EpCAM) and LewisY antigen expression. Clin Exp Immunol 2001;123:9-14. (Pubitemid 32118830)
17. Thurmond LM, Stimmel JB, Ingram AC, Ryan CH, Murray DM, Eberwein DJ, et al. Adenocarcinoma cells exposed in vitro to Navelbine or Taxol increase Ep-CAM expression through a novel mechanism. Cancer Immunol Immunother 2003;52:429-37. (Pubitemid 36831364)
18. Eming SA, Krieg T, Davidson JM. Infl ammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 2007;127:514-25.
19. Burster T, Macmillan H, Hou T, Schilling J, Truong P, Boehm BO, et al. Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules. Immunology 2010;130:436-46.
20. le Maire M, Champeil P, Moller JV. Interaction of membrane proteins and lipids with solubilizing detergents. Biochim Biophys Acta 2000;1508:86-111.
21. Guillon G, Roy C, Jard S. A systematic study of effects of nonionic detergents on solubilization and activity of pig kidney adenylate cyclase. Eur J Biochem 1978;92:341-8. (Pubitemid 9084879)
22. Ayorinde FO, Gelain SV, Johnson JH Jr, Wan LW. Analysis of some commercial polysorbate formulations using matrix-assisted laser desorption/ionization time-of-fl ight mass spectrometry. Rapid Commun Mass Spectrom 2000;14:2116-24.
23. Went PT, Lugli A, Meier S, Bundi M, Mirlacher M, Sauter G, et al. Frequent EpCam protein expression in human carcinomas. Hum Pathol 2004;35:122-8. (Pubitemid 38133932)
24. Osta WA, Chen Y, Mikhitarian K, Mitas M, Salem M, Hannun YA, et al. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 2004;64:5818-24. (Pubitemid 39095582)
25. Litvinov SV, Velders MP, Bakker HA, Fleuren GJ, Warnaar SO. Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J Cell Biol 1994;125:437-46. (Pubitemid 24135956)
26. Rao CG, Chianese D, Doyle GV, Miller MC, Russell T, Sanders RA Jr, et al. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. Int J Oncol 2005;27:49-57.
27. Armstrong A, Eck SL. EpCAM: a new therapeutic target for an old cancer antigen. Cancer Biol Ther 2003;2:320-6.
28. Zafi r-Lavie I, Michaeli Y, Reiter Y. Novel antibodies as anticancer agents. Oncogene 2007;26:3714-33. (Pubitemid 46842707)
29. Martin VM, Siewert C, Scharl A, Harms T, Heinze R, Ohl S, et al. Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS. Exp Hematol 1998;26:252-64. (Pubitemid 28106837)
30. Witzig TE, Bossy B, Kimlinger T, Roche PC, Ingle JN, Grant C, et al. Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy. Clin Cancer Res 2002;8:1085-91. (Pubitemid 34517644)
31. Allan AL, Keeney M. Circulating tumor cell analysis: technical and statistical considerations for application to the clinic. J Oncol 2010;2010:426218.
32. Pachmann UA, Hekimian K, Carl S, Ruediger N, Rabenstein C, Pachmann K. Comparing sequential steps for detection of circulating tumor cells: more specifi c or just less sensitive ? Webmed Central Cancer 2011:2 WMC001490.
33. Nakamura K, Yamaji T, Crocker PR, Suzuki A, Hashimoto Y. Lymph node macrophages, but not spleen macrophages, express high levels of unmasked sialoadhesin: implication for the adhesive properties of macrophages in vivo. Glycobiology 2002;12:209-16. (Pubitemid 34567867)
34. Hjelm F, Carlsson F, Getahun A, Heyman B. Antibodymediated regulation of the immune response. Scand J Immunol 2006;64:177-84.
35. Haslett C. Granulocyte apoptosis and infl ammatory disease. Br Med Bull 1997;53:669-83. (Pubitemid 27397318)
36. Pachmann K. Longtime recirculating tumor cells in breast cancer patients. Clin Cancer Res 2005;11:5657.